CME Presentations

Endometrial Cancer



  • Gottfried Konecny, MD

    Gottfried Konecny, MD

    Gottfried Konecny, MD

    Professor of Medicine and Obstetrics/Gynecology, Divisions of Hematology/Oncology and Gynecologic Oncology

    Gottfried Konecny, MD, is Professor of Medicine and Obstetrics/Gynecology in the Divisions of Hematology/Oncology and Gynecologic Oncology at the David Geffen School of Medicine at the University of California Los Angeles (UCLA). Dr. Konecny directs the Medical Gynecologic Oncology Program and heads the Drug Development Program for Gynecologic Oncology in the Translational Oncology Research Lab at UCLA. His ongoing research interests include drug discovery and novel therapeutics for ovarian, uterine, and cervical cancer and clinical trial development. Also, he is a member of the European Academy of Arts and Sciences, has served as ASCO program committee chair and co-chair for the NCI Ovarian Cancer Clinical Trials Planning Group, and is a member of the NCCN ovarian cancer consensus panel.

CME Information

Global Logo PQH Logo
Treatment Decision‐Making in Advanced Endometrial Cancer with or without MSI/dMMR
This activity is jointly provided by Global Education Group and PlatformQ Health Education, LLC.


This educational activity is supported by an educational grant from GlaxoSmithKline.


This activity was released on November 22, 2022 and is valid until May 22, 2023. Requests for credit must be made no later than May 22, 2023.


The educational design of this activity addresses the needs of medical oncologists, gynecologic oncologists, OB/GYNs, pathologists, nurse practitioners, physician assistants, oncology nurses, and other HCPs involved in the care of patients with endometrial cancer.


The treatment landscape for endometrial cancer is evolving, with increasing use of histology/molecular testing-based treatment approaches that differentiate tumors with or without microsatellite instability-high (MSI-H) and mismatch repair deficiency (dMMR). For therapies to be effective, clinicians must identify those patients most likely to benefit from a specific treatment and select the option best suited to each individual patient. To ensure that all patients with endometrial cancer benefit equitably from these treatment advances, it is crucial that barriers to care be addressed appropriately.

In this activity, Dr. Gottfried Konecny will analyze the latest clinical evidence on treatment options for recurrent endometrial cancer. Dr. Konecny will review strategies for personalizing treatment selection with biomarker testing and explore approaches for sequencing therapy and minimizing adverse events. Factors that lead to disparities in treatment will be discussed and strategies to minimize those inequities and improve patient outcomes and quality of life will be presented.


After completing this activity, the participant should be better able to:
  • Discuss strategies to reduce disparities in care and improve patient QoL
  • Evaluate the relevance of histology and molecular testing to facilitate treatment decision‐ making for second‐line treatment of patients with endometrial cancer
  • Assess clinical‐trial evidence on new and practice‐changing therapies for the management of recurrent endometrial cancer
  • Evaluate strategies to monitor treatment‐emergent adverse events associated with current and emerging treatment regimens


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and PlatformQ Health Education, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.


Global Education Group designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 0.5 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.


This activity should take approximately 30 minutes to complete.


In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a score of 70% on the post-test.


Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.


There is no fee for this educational activity.


Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

Name of Faculty or Presenter Reported Financial Relationship
Gottfried E. Konecny, MD
Professor of Medicine and Ob/Gyn
Medical Gynecologic Oncology
University of California, Los Angeles
Speakers’ Bureau: AstraZeneca, Clovis, GlaxoSmithKline, Merck

The planners and managers have the following relevant financial relationships with ineligible companies:

Name of Planner or Manager Reported Financial Relationship
Lindsay Borvansky Nothing to disclose
Andrea Funk Nothing to disclose
Liddy Knight Nothing to disclose
Ashley Cann Nothing to disclose
Lauren Sinclair Nothing to disclose
Tariqa Ackbarali Nothing to disclose
Vandana Gupta Nothing to disclose
Alissa Yost Nothing to disclose


This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PlatformQ Health Education, LLC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Accreditation Support: For information about the accreditation of this program, please contact Global at 303-395-1782 or

Technical Support: For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at